Another animal study revealed that nCGA protects cardiomyocytes from TNF-α–induced injury via inhibition of NF-κB signals, providing a novel therapeutic alternative for the prevention and treatment of heart failure [32]. The gene discussed is NFKB1; the disease is heart failure.